APPLIED MOLECULAR TRANSPORT INC.

EDGAR

Market value is not computed: no recent price is available.

26 filing records in this dataset, filed from 2020-05-18 to 2023-11-09. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Cash and cash equivalents
18.1 million USD Source
Exact value

18103000 USD

Long-term debt including current maturities
Not available
Shares outstanding
40.9 million shares Source
Exact value

40893507 shares

Reported share-count change

5.01% · 1.95 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 38943097 shares · 2022-09-30· Source
  • 40893507 shares · 2023-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-74.8 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Net income: -126325000 USD · 2022-01-01 – 2022-12-31 Source
  • Net income: -103726000 USD · 2022-01-01 – 2022-09-30 Source
  • Net income: -27917000 USD · 2023-01-01 – 2023-03-31 Source
  • Net income: -17333000 USD · 2023-04-01 – 2023-06-30 Source
  • Net income: -6937000 USD · 2023-07-01 – 2023-09-30 Source

Operating cash flow

-60 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Operating cash flow: -93900000 USD · 2022-01-01 – 2022-12-31 Source
  • Operating cash flow: -79084000 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -19298000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -40821000 USD · 2023-01-01 – 2023-06-30 Source
  • Operating cash flow: -19298000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -45220000 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -40821000 USD · 2023-01-01 – 2023-06-30 Source

Capital expenditure

452 thousand USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Capital expenditure: 4152000 USD · 2022-01-01 – 2022-12-31 Source
  • Capital expenditure: 4146000 USD · 2022-01-01 – 2022-09-30 Source
  • Capital expenditure: 61000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 446000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 61000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 446000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 446000 USD · 2023-01-01 – 2023-06-30 Source

Free cash flow

-60.5 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Operating cash flow: -93900000 USD · 2022-01-01 – 2022-12-31 Source
  • Operating cash flow: -79084000 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -19298000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -40821000 USD · 2023-01-01 – 2023-06-30 Source
  • Operating cash flow: -19298000 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -45220000 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -40821000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 4152000 USD · 2022-01-01 – 2022-12-31 Source
  • Capital expenditure: 4146000 USD · 2022-01-01 – 2022-09-30 Source
  • Capital expenditure: 61000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 446000 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 61000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 446000 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 446000 USD · 2023-01-01 – 2023-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-11-09.

Financial data available through: 2022-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 4 of 11 periods available· newest 2022-12-31
  • Net income: 4 of 11 periods available· newest 2022-12-31
  • Operating cash flow: 4 of 11 periods available· newest 2022-12-31
  • Capital expenditure: 4 of 11 periods available· newest 2022-12-31
  • Total assets: 4 of 11 periods available· newest 2022-12-31
  • Total liabilities: 4 of 11 periods available· newest 2022-12-31
  • Current assets: 4 of 11 periods available· newest 2022-12-31
  • Current liabilities: 4 of 11 periods available· newest 2022-12-31
  • Cash and cash equivalents: 4 of 11 periods available· newest 2022-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 4 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 26.04 million

    Prior period

    −USD 100.29 million

    –

    Current period

    −USD 126.33 million

    –

    Exact inputs and evidence

    -126325000 − -100287000 = -26038000 USD

    -100287000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -126325000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 11.29 million

    Prior period

    −USD 82.61 million

    –

    Current period

    −USD 93.9 million

    –

    Exact inputs and evidence

    -93900000 − -82609000 = -11291000 USD

    -82609000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -93900000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +122.7%

    Prior period

    USD 1.86 million

    –

    Current period

    USD 4.15 million

    –

    Exact inputs and evidence

    4152000 − 1864000 = 2288000 USD

    1864000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    4152000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2019 2019-01-01 – 2019-12-31
−USD 28.04 million
Exact value

Exact value: -28043000 USD

2019-01-01 – 2019-12-31: -28043000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 26.97 million
Exact value

Exact value: -26967000 USD

2019-01-01 – 2019-12-31: -26967000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.15 million
Exact value

Exact value: 2153000 USD

2019-01-01 – 2019-12-31: 2153000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 29.12 million
Calculation and evidence

-26967000 − 2153000 USD

Exact free cash flow: -29120000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 66.56 million
Exact value

Exact value: -66564000 USD

2020-01-01 – 2020-12-31: -66564000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 58.89 million
Exact value

Exact value: -58894000 USD

2020-01-01 – 2020-12-31: -58894000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 5.32 million
Exact value

Exact value: 5315000 USD

2020-01-01 – 2020-12-31: 5315000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 64.21 million
Calculation and evidence

-58894000 − 5315000 USD

Exact free cash flow: -64209000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 100.29 million
Exact value

Exact value: -100287000 USD

2021-01-01 – 2021-12-31: -100287000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 82.61 million
Exact value

Exact value: -82609000 USD

2021-01-01 – 2021-12-31: -82609000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.86 million
Exact value

Exact value: 1864000 USD

2021-01-01 – 2021-12-31: 1864000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 84.47 million
Calculation and evidence

-82609000 − 1864000 USD

Exact free cash flow: -84473000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 126.33 million
Exact value

Exact value: -126325000 USD

2022-01-01 – 2022-12-31: -126325000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 93.9 million
Exact value

Exact value: -93900000 USD

2022-01-01 – 2022-12-31: -93900000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4.15 million
Exact value

Exact value: 4152000 USD

2022-01-01 – 2022-12-31: 4152000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 98.05 million
Calculation and evidence

-93900000 − 4152000 USD

Exact free cash flow: -98052000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

26 filings · 923 latest values · 923 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001801777, 1801777, AMTI, edgar:1801777

Also known as APPLIED MOLECULAR TRANSPORT INC., Applied Molecular Transport Inc., Applied Molecular Transport LLC